China Pharma Holdings, Inc. ("China Pharma"), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release its second quarter of year 2012 financial results before the market opens on Wednesday, August 15, 2012.

The Company will hold a conference call at 8:30 am ET on August 15, 2012 to discuss second quarter of year 2012 results.

 
About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company’s cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions.

 
The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc

SOURCE: marketwatch.com

 

Editorial Message 

This site contains materials from other clearly stated media sources for the purpose of discussion stimulation and content enrichment among our members only. whatsonsanya.com does not necessarily endorse their views or the accuracy of their content. For copyright infringement issues please contact editor@whatsonsanya.com